Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole)

Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole)
  • Detailed references
  • Editorially prepared
  • Download as PDF / PPT

Statistics report about AstraZeneca and its top brands Crestor and Nexium

Table of contents

    • AstraZeneca's top products based on revenue 2021-2022

    • AstraZeneca's revenue from top product Crestor 2006-2022

    • AstraZeneca's revenue from Crestor by region 2018-2022

    • Total savings of top generic drugs in U.S. 2021

    • AstraZeneca's revenue from top product Nexium 2006-2022

    • AstraZeneca's revenue from Nexium by region 2018-2022

    • Leading antacid tablet brands in the U.S. 2019, based on sales

    • Sales value of leading drugs Japan FY 2021

    • U.S. household expenditure on prescription drugs 2007-2021

    • Esomeprazole prescriptions number U.S. 2007-2020

    • Esomeprazole out of pocket cost U.S. 2004-2020

    • Rosuvastatin out-of-pocket cost U.S. 2004-2020

    • Number of rosuvastatin prescriptions in the U.S. 2004-2020

    • AstraZeneca: ad spend in the U.S. 2012-2019

    • Leading pharmaceutical companies in the U.S. 2020, by DTC

    • Pharma companies with largest print ad spend in the U.S. 2020

More than 7,500
companies
trust
Statista

Recommended reports

Recent reports

You may also be interested in...

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!